Table 5.
Summary of Sub-group Analyses Exploring Heterogeneity among Trials Reporting Motor Activity Log–Amount of Use Sub-scale Findings
| Sub-group comparison | No. of studies (n) | Effect estimate (95% CI) | Test for difference | p-value |
|---|---|---|---|---|
| Criteria for learned non-use used? | ||||
| Yes | 9 (283) | 1.01 (0.81–1.22) | χ2=0.83 | 0.36 |
| No | 3 (69) | 1.26 (0.77–1.75) | ||
| Time post stroke | ||||
| <6 mo | 3 (66) | 1.88 (1.58–2.17) | χ2=33.41 | 0.001 |
| ≥6 mo | 5 (178) | 0.62 (0.31–0.93) | ||
| Exclude participants with spasticity? | ||||
| Yes | 7 (180) | 1.61 (1.41–1.82) | χ2=23.9 | 0.001 |
| No | 5 (138) | 0.61 (0.26–0.95) | ||
| Sample size of trial | ||||
| ≥30 participants | 7 (265) | 0.84 (0.59–1.09) | χ2=6.63 | 0.01 |
| <30 participants | 5 (87) | 1.34 (1.05–1.64) | ||
| Total PEDro score | ||||
| ≥7 | 9 (313) | 0.61 (0.38–0.84) | χ2=46.34 | 0.001 |
| <7 | 3 (39) | 2.03 (1.69–2.38) |